PureCycle Technologies, Inc. (PCT) Stock Price & Analysis
PureCycle Technologies, Inc. (PCT) closed at USD 2.77 on Friday, October 23, 2026, down 0.36% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 2.78; the Oct 23, 2026 session ranged USD 2.59–2.86 on volume of 5,145,964 shares. Market capitalization is $556.51M, with a 52-week range of USD 2.59–14.2 (NCM). Source: Nexqual, retrieved October 24, 2026 at 23:57 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PCT.md
Key facts (PCT)
- Last four reported quarters (through Jun 30, 2026): revenue $13.8M, net income -$223M (-1618.8% margin), free cash flow -$212M (SEC filings).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $99K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.60 on a 1–5 scale) (5 analysts), mean target USD 10.6 (range 6–17).
- Total return with dividends: 1Y -78.8% vs S&P 500 +13.4%; 5Y -79.3% vs S&P 500 +76.9%.
- Next earnings: 2026-11-04, EPS estimate USD -0.25, revenue estimate $8.3M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (PCT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0K | $0K | $8.4M | $13.8M |
| Operating income | — | — | -$114M | -$145M | -$181M | -$181M |
| Net income | -$77.5M | -$84.7M | -$102M | -$289M | -$183M | -$223M |
| EPS (diluted) | -$0.79 | -$0.55 | -$0.63 | -$1.75 | -$1.21 | — |
| Free cash flow | -$192M | -$353M | -$249M | -$200M | -$184M | -$212M |
| Operating margin | — | — | — | — | -2171.6% | -1316.8% |
| Net margin | — | — | — | — | -2185.1% | -1618.8% |
| Cash + short-term investments | $201M | $162M | $122M | $15.7M | $170M | — |
| Total debt | $250M | $250M | — | — | — | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (PCT)
P/S 40.4x · P/B 35.9x · FCF yield -38.14% · Earnings yield -40.04% · Buyback yield (TTM) 0.83%
Insider purchases (SEC Form 4, open-market, last ~7 months) (PCT)
1 purchase, $99K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-04 | Musa Fernando | Director | 15,479 | $99K | 6.38 | Too little history (no open-market trades in 2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (PCT)
Consensus Hold (mean 2.60 on a 1–5 scale), 5 analysts; mean target USD 10.6 (low 6, high 17).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-07 | Cantor Fitzgerald | Target lowered | Overweight | $14 → $12 |
Total return (dividends reinvested) (PCT)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -78.8% | -79.3% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -79.0% | -27.1% |
| Volatility (annualized) | 81.9% | 88.9% |
| Max drawdown | -80.1% (Jun 2026→Oct 2026) | -83.6% (Jul 2025→Oct 2026) |
PCT suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | PCT | “From time to time, PCT may be involved in legal proceedings and investigations arising in the ordinary course of business, including those relating to employment matters, relationships with our feedstock suppliers and offtake partners as well as strategic partners, intellectual property disputes, additional volatility in the market price of our securities and other business matters.” |
Quoted from the company's 10-K filed Feb 26, 2026.
Companies that name PCT in their SEC reports
| Relationship to PCT | Company | Filing | Sentence |
|---|---|---|---|
| partner | Innventure, Inc. (INV) | 10-K Mar 30, 2026 | “In March 2021, the Company entered into a purchase option agreement with the ESG Fund to sell 145,161 shares of PureCycle Technologies, Inc. ("PCT") common stock with an exercise price of $1.” |
PCT company outlook (results filed Aug 6, 2026)
- “Anticipated project debt is sized to fund remaining construction • Thailand feedstock and offtake: seven signed LOIs with Thai suppliers covering more than the plant's annual feedstock requirement (1.5-2.4x's coverage), and 14 signed sales offtake LOIs (0.8-1.4x's coverage) • Belgium Facility permits expected by 1H 2027;”
- “Project Spend Project spend in Q2 2026 totaled $20.9 million, bringing first-half 2026 project spend to approximately $35 million.”
- “Fiscal year 2026 project spend expectations are $45 to $50 million, up from the prior range of $39 to $45 million.”
- “Second-half 2026 spend of $10 to $12 million remains contingent on project gating decisions and the timing of project financing.”
Quoted word-for-word from the SEC 8-K results press release.
PCT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.25 | $-0.26 | -2.9% | $8.3M | 4 |
| Next quarter (ends Dec 2026) | $-0.21 | $-0.22 | -2.3% | $14.0M | 4 |
| Current fiscal year (ends Dec 2026) | $-1.38 | $-1.00 | +37.9% | $30.9M | 4 |
| Next fiscal year (ends Dec 2027) | $-0.70 | $-0.80 | -12.2% | $112.1M | 4 |
PCT options: expected move
Options price a move of about ±23.0% (±$0.65) by Nov 6, 2026, which includes earnings on Nov 4, 2026; the earnings reaction alone is priced at about ±15.6%. Over the last 8 reports the stock moved ±11.5% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 6 | 100.4% | ±13.3% |
| Nov 6, 2026 | 13 | 138.5% | ±23.0% |
| Nov 13, 2026 | 20 | 141.8% | ±28.3% |
| Nov 20, 2026 | 27 | 135.2% | ±30.9% |
| Nov 27, 2026 | 34 | 125.0% | ±31.8% |
| Dec 4, 2026 | 41 | 124.0% | ±34.5% |
| Dec 18, 2026 | 55 | 119.1% | ±38.0% |
| Jan 15, 2027 | 83 | 119.1% | ±43.3% |
30-day implied volatility 123% vs 55.3% realized over the last 30 trading days. Put/call ratio (volume) 0.53. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 24, 2026 at 23:57 UTC)
| Price | USD 2.77 |
|---|---|
| Change | ▼ 0.36% (down) |
| Previous Close | USD 2.78 |
| Open | USD 2.75 |
| Day Range | USD 2.59 – 2.86 |
| 52-Week Range | USD 2.59 – 14.2 |
| Volume | 5,145,964 shares |
| Market Cap | $556.51M |
| Exchange | NCM |
Technical Analysis (PCT)
Nexqual's technical model rates PCT "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 23:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 12.71 (oversold) |
| vs SMA50 | Below (USD 5.17) |
| MACD | -0.7 (negative) |
Analyst Ratings (PCT)
Wall Street analysts rate PCT "Hold" based on 5 analysts, with a mean price target of USD 10.6 (range USD 6–17), per Nexqual as of October 24, 2026 at 23:57 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 10.6 |
| High Target | USD 17 |
| Low Target | USD 6 |
| Buy / Hold / Sell | 2 / 3 / 0 |
Earnings (PCT)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD -0.25 |
| Revenue Estimate | $8.28M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.3 vs est -0.28 ▼ miss |
| 2026-03-31 | USD -0.3 vs est -0.24 ▼ miss |
| 2025-12-31 | USD -0.07 vs est -0.25 ▲ beat |
| 2025-09-30 | USD -0.31 vs est -0.26 ▼ miss |
Source: Nexqual, October 24, 2026 at 23:57 UTC.
Financials & Fundamentals (PCT)
| Total Revenue | $13.76M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +173.50% |
| Gross Margin | +0.00% |
| Operating Margin | -916.09% |
| Profit Margin | +0.00% |
| ROE | -61.56% |
| Debt / Equity | 1.63 |
| Current Ratio | 2.6 |
| Total Cash | $224.82M |
| Total Debt | $539.53M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$212.25M (-1542.1% of revenue) |
Source: Nexqual, October 24, 2026 at 23:57 UTC.
Financial Health Score (PCT)
Nexqual rates PureCycle Technologies, Inc.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 23:57 UTC.
| Growth | Strong — Revenue +174% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Weak — $225M cash vs $540M debt |
| Cash Flow | Weak — FCF negative: -$212M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -62%, ROA -10.2% |
Ownership (PCT)
| Insider Ownership | +2.67% |
|---|---|
| Institutional Ownership | +89.57% |
| Shares Outstanding | 200.90M |
| Float | 161.78M |
| Short % of Float | +40.16% |
Source: Nexqual, October 24, 2026 at 23:57 UTC.
Leadership (PCT)
PureCycle Technologies, Inc. is led by Dustin Olson, CEO & Director, per Nexqual as of October 24, 2026 at 23:57 UTC.
| CEO & Director | Dustin Olson |
|---|---|
| Chief Financial Officer | Donald Carpenter |
| Executive Vice President of Manufacturing and Tech | Brett Hafer |
| Director of Investor Relations | Eric DeNatale |
| Vice President of Human Resources | Kelly Ross |
Major Backers & Investors (PCT)
Notable institutional backers of PureCycle Technologies, Inc. include Sylebra Capital LLC, Abundance Wealth Counselors, Longview Asset Management, LLC, according to Nexqual as of October 24, 2026 at 23:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sylebra Capital LLC | 16.96% |
| Abundance Wealth Counselors | 12.6% |
| Longview Asset Management, LLC | 4.84% |
| Alyeska Investment Group, L.p. | 2.84% |
| Rokos Capital Management, LLP | 2.45% |
| Shay Capital LLC | 2.31% |
| Simplify Exchange Traded Funds-Simplify Health Care ETF | 1.52% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 7.69% |
| BlackRock | 5.53% |
| Geode Capital | 1.91% |
Source: Nexqual, October 24, 2026 at 23:57 UTC.
From PureCycle Technologies, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Our unique Purification process separates colors, odors, other plastics, and additives through a physical separation process.
- Our enhanced sorting allows us to process mixed plastic bales.
- We are currently in the process of completing a capital project at the Ironton Facility that will allow us to perform the majority of our compounding activities and reduce reliance on third-party operators, except to supplement the Ironton Facility's compounding activities or for specific compounding activities, as needed.
Legal & Regulatory Risks (Item 1A, quoted)
- Climate change, or legal, regulatory or market measures to address climate change may materially adversely affect the Company's financial condition and business operations.
- Risks Related to Regulatory Developments
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDZI | Cadiz, Inc. | USD 4.34 | ▲ 6.77% |
| ADUR | Aduro Clean Technologies Inc. | USD 9.77 | ▼ 2.98% |
| ERII | Energy Recovery, Inc. | USD 6.68 | ▲ 0.15% |
| ZWS | Zurn Elkay Water Solutions Corp | USD 48.55 | ▼ 0.23% |
| VLTO | Veralto Corp | USD 104.33 | ▼ 0.54% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 23:57 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt